featured
Effectiveness and Safety of Risankizumab in Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multicenter Study on Effectiveness and Safety of Risankizumab in Psoriasis: An Italian 16-Week Real-Life Experience During the COVID-19 Pandemic
J Eur Acad Dermatol Venereol 2020 Oct 20;[EPub Ahead of Print], K Hansel, A Zangrilli, L Bianchi, K Peris, A Chiricozzi, A Offidani, F Diotallevi, MC Fargnoli, M Esposito, P Amerio, G Gualdi, L Bianchi, L StingeniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.